glp-1 class drugs receptor agonists GLP-1 Agonists: A Comprehensive Overview

The findings showed Ozempic had a 1% incidence rate of stomach paralysis, liraglutide had 0.7%, and Contrave had 0.3%

Available from: Holmes GM, Browning KN, Tong M, Qualls-Creekmore E, Travagli RA (2009) Vagally mediated effects of glucagon-like peptide 1: in vitro and in vivo gastric actions

Individual results vary based on factors like starting weight, lifestyle changes, and medical conditions

Understanding dementia and its link to diabetes The prevalence and impact of dementia Dementia is a broad term that encompasses various neurodegenerative disorders characterized by a decline in cognitive function

Bergman AJ, Cote J, Yi B, et al

The telogen effluvium connection Telogen effluvium deserves its own deep dive because it accounts for the vast majority of hair loss seen with GLP-1 medications